Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Plasma biomarkers can be used to detect tau pathology in Down syndrome
Plasma p-tau217 proved an accurate blood-based biomarker of both tau and amyloid-beta pathological brain alterations for those with Down syndrome and may be used alone or with age as a covariate, per a study published in JAMA Neurology.
Nonalcoholic fatty liver disease linked to increased risk for dementia
Patients with nonalcoholic fatty liver disease had an increased risk for dementia, with stronger risk existing for those with comorbid heart disease or stroke, according to a study published in Neurology.
Log in or Sign up for Free to view tailored content for your specialty!
Flu-like illness confers stroke risk in younger patients; vaccination may offer protection
Influenza-like illness conferred increased odds of 30-day stroke in young patients, but vaccination was associated with lower risk compared with non-vaccination, according to data published in Stroke.
Ketamine effective treatment for neonatal, pediatric epilepsy
Treatment with ketamine significantly improved seizure occurrence related to refractory status epilepticus in both neonates and children, according to results of a study published in Neurology.
Labcorp blood test identifies signs of neurodegenerative disease
Labcorp Diagnostics announced the launch of the first widely accessible blood test that provides direct evidence of neurodegeneration and neuronal injury.
Erythropoietin fails to lower death in neonates with neurologic condition
High-dose erythropoietin failed to lower the risk for death among newborns undergoing therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy, according to study findings published in The New England Journal of Medicine.
Eptinezumab reduced migraine effects for adults with previous treatment failures
For adults with migraine and repeated preventive treatment failures, eptinezumab produced significant reductive effects compared with placebo, along with acceptable safety and tolerability, per a study published in Lancet Neurology.
Decompressive craniectomy linked to lower mortality, improved recovery
Patients with posttraumatic refractory intracranial hypertension treated with decompressive craniectomy showed reduced mortality and improved recovery at 24 months compared with standard care, per a study published in JAMA Neurology.
FDA grants fast track, orphan drug designations to glioblastoma therapy
The FDA granted fast track and orphan drug designations to Alpheus Medical’s CV-01 delivery of sonodynamic therapy for treatment of recurrent glioblastoma.
FDA places hold on phase 2/3 clinical trial of stroke therapy
Biopharmaceutical company DiaMedica Therapeutics Inc. announced that the FDA placed a clinical hold on its phase 2/3 ReMEDy2 trial of a synthetic protein therapy for treatment of acute ischemic stroke.
-
Headline News
‘Unethical’ conversion therapy tied to ‘poor mental health’
October 01, 20242 min read -
Headline News
Mental health counseling more effective at reducing preterm birth vs. antidepressants
October 01, 20242 min read -
Headline News
Discharge setting following sepsis hospitalization linked to readmission
October 03, 20242 min read
-
Headline News
‘Unethical’ conversion therapy tied to ‘poor mental health’
October 01, 20242 min read -
Headline News
Mental health counseling more effective at reducing preterm birth vs. antidepressants
October 01, 20242 min read -
Headline News
Discharge setting following sepsis hospitalization linked to readmission
October 03, 20242 min read